Inmunología Tumoral

Publicaciones

  • 01/07/2026

    Cancer diagnosis & prognosis

    HER2 Expression and Nuclear Localization in Clear Cell Renal Cell Carcinoma: Implications for Prognosis and Therapeutic Targeting

    María Alicia CortésHéctor Marcelo MarínNadia BarbásRosalia Cordo-RusoLucia RottGustavo Emilio GiusianoLuis Antonio Merino

  • 20/05/2026

    Molecular therapy. Oncology.

    Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma

    Bárbara BueloniMariel FuscoEsteban FioreMariana MalviciniMaría Jose CanteroLucía LameroliMailín CasadeiBrian Martinez RuizFlorencia MercoglianoEva SantamaríaCatalina AtorrasagastiJosepmaria ArgemiAli CanbayJuan BayoGuillermo Mazzolini

  • 27/04/2026

    Scientific report

    Human Tamm-Horsfall protein as a novel antitumor therapy for triple negative breast cancer and other solid tumors

    María Florencia MercoglianoSofia BruniMara De MartinoLiliana BalanianMiguel A CastellanoJosé GroismanFelipe InserraRoxana SchillaciElena M V de Cavanagh

  • 27/10/2025

    International journal of molecular sciences

    4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer

    Mariel FuscoCarlos Rafael PicónMarco Aurelio DiazJuan BayoPaula Constanza Arriola BenitezFlavia PiccioniNoelia GómezMara StincoJavier Martínez MartinezJosé Nicolás MinattaRicardo AmorínMartina VillarValentina SoleIgnacio CassolMauricio De MarziManglio Miguel RizzoMaría Florencia MercoglianoMariana Malvicini

  • 22/02/2025

    Translational oncology

    Mucin 4 expression is associated with metastasis in triple-negative breast cancer and can be tackled by soluble TNF blockade, improving immunotherapy outcome

    Florencia MauroSofia BruniAgustina DupontAldana ScheyAgustina BadaliniGloria InurrigarroSilvina FigurelliSabrina BarchukDaniel Lopez Della VecchiaErnesto Gil DezaYanina RivensonAgustin NavaElmer FernandezAlejandro UrtregerRosalia Cordo RussoMaría Florencia MercoglianoRoxana Schillaci

  • 01/02/2024

    Nature reviews. Endocrinology

    Pituitary stem cells: past, present and future perspectives

    María Inés Pérez MillánLeonard Y M CheungFlorencia MercoglianoMaria Andrea CamillettiGonzalo T Chirino FelkerLucia N MoroSantiago MiriukaMichelle L BrinkmeierSally A Camper

  • 22/05/2023

    Frontiers in oncology

    Cancer immune exclusion: breaking the barricade for a successful immunotherapy

    Sofia Bruni, María Florencia Mercogliano, Florencia Luciana Mauro, Rosalia Inés Cordo Russo, Roxana Schillaci

  • 26/03/2023

    Cancers

    Emerging Targeted Therapies for HER2-Positive Breast Cancer

    María Florencia Mercogliano, Sofía Bruni, Florencia Luciana Mauro, Roxana Schillaci

  • Journal for Immunotherapy of Cancer

    01/03/2023

    Journal for immunotherapy of cancer

    Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression

    Sofia Bruni, Florencia L Mauro, Cecilia J Proietti, Rosalia I Cordo-Russo, Martin A Rivas, Gloria Inurrigarro, Agustina Dupont, Dario Rocha, Elmer A Fernández, Ernesto Gil Deza, Daniel Lopez Della Vecchia, Sabrina Barchuk, Silvina Figurelli, David Lasso, Adrián D Friedrich, María C Santilli, María V Regge, Gabriel Lebersztein, Claudio Levit, Fabiana Anfuso, Teresa Castiglione, Patricia V Elizalde, Maria F Mercogliano, Roxana Schillaci

  • 09/05/2022

    Cell Death and Disease

    Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer

    Santiago Madera, Franco Izzo, María F Chervo, Agustina Dupont, Violeta A Chiauzzi, Sofia Bruni, Ezequiel Petrillo, Sharon S Merin, Mara De Martino, Diego Montero, Claudio Levit, Gabriel Lebersztein, Fabiana Anfuso, Agustina Roldán Deamicis, María F Mercogliano, Cecilia J Proietti, Roxana Schillaci, Patricia V Elizalde, Rosalía I Cordo Russo